Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) — Cash Flow Reinvestment Rate
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) has a Cash Flow Reinvestment Rate of 0.33x as of December 2025, reinvesting $43.17 Million (capex $43.17 Million ) from operating cash flow of $130.31 Million. Check how high is Amneal Pharmaceuticals, Inc. Class A Com's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Amneal Pharmaceuticals, Inc. Class A Common Stock Cash Flow Reinvestment Rate (2014–2025)
Historical reinvestment intensity for Amneal Pharmaceuticals, Inc. Class A Common Stock across 12 annual periods. Explore Amneal Pharmaceuticals, Inc. Class A Com long-term investment allocation to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Amneal Pharmaceuticals, Inc. Class A Common Stock (2014–2025)
Year-by-year capital reinvestment analysis for Amneal Pharmaceuticals, Inc. Class A Common Stock. For live market cap and broader valuation context, see Amneal Pharmaceuticals, Inc. Class A Com market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.21x | $70.06 Million | $339.99 Million | $70.06 Million | ▼ -55.9% |
| 2024 | 0.47x | $137.99 Million | $295.10 Million | $74.99 Million | ▲ +16.8% |
| 2023 | 0.40x | $138.38 Million | $345.58 Million | $69.19 Million | ▼ -90.2% |
| 2022 | 4.07x | $264.90 Million | $65.10 Million | $90.59 Million | ▲ +306.8% |
| 2021 | 1.00x | $241.91 Million | $241.82 Million | $47.73 Million | ▼ -0.1% |
| 2020 | 1.00x | $379.38 Million | $379.00 Million | $61.84 Million | ▼ -98.5% |
| 2019 | 68.63x | $117.01 Million | $1.71 Million | $97.43 Million | ▲ +3380.0% |
| 2018 | 1.97x | $493.47 Million | $250.23 Million | $97.09 Million | ▲ +117.0% |
| 2017 | 0.91x | $212.82 Million | $234.19 Million | $114.27 Million | ▼ -58.0% |
| 2016 | 2.17x | $249.21 Million | $115.06 Million | $124.61 Million | ▲ +93.5% |
| 2015 | 1.12x | $117.38 Million | $104.88 Million | $117.38 Million | ▲ +58.3% |
| 2014 | 0.71x | $79.38 Million | $112.26 Million | $79.38 Million | — |